|
NCT04183608
|
An Open-label Randomized Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating adaLimumab: The CONTROL Trial (CONTROL)
|
En recrutement
|
01 juin 2023
|
|
NCT04234360
|
Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation: a Double-blind, Randomized, Controlled Trial (eo-Drive)
|
En recrutement
|
20 mars 2023
|
|
NCT04003220
|
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker (ICTUS)
|
Statut inconnu
|
20 mars 2023
|
|
NCT03891914
|
Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma (MYELOCHOL)
|
Statut inconnu
|
20 mars 2023
|
|
NCT03869619
|
REAL WORLD DATA IN LYMPHOMA AND SURVIVAL IN ADULTS (REALYSA)
|
En recrutement
|
20 mars 2023
|
|
NCT02355379
|
Randomised Phase III Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over Intergroup Trial: Ffcd, Gercor, Gerico, Unicancer-gi (ADAGE)
|
En recrutement
|
20 mars 2023
|
|
NCT02237313
|
Identification of Vulnerability Factors in the Course of Pemphigus Patients - SHS Pemphigus Clinical Trial (SHS-Pemphigus)
|
Statut inconnu
|
20 mars 2023
|
|
NCT02066454
|
Evaluation of the Use of an Oral Direct Anti-Xa Anticoagulant, Apixaban, in Prevention of Venous Thromboembolic Disease in Patients Treated With IMiDs During Myeloma : a Pilot Study (MYELAXAT)
|
Statut inconnu
|
20 mars 2023
|
|
NCT04365205
|
Effect of Benralizumab on Airway Remodeling in Asthma (BENRAMOD)
|
En recrutement
|
20 mars 2023
|
|
NCT00224341
|
|
Statut inconnu
|
29 octobre 2022
|
|
NCT00221780
|
Importance of Left Ventricular Pacing Site in Biventricular Resynchronization Therapy for Severe Heart Failure
|
Statut inconnu
|
29 octobre 2022
|